51 related articles for article (PubMed ID: 38601488)
1. Polio endgame: the global switch from tOPV to bOPV.
Garon J; Seib K; Orenstein WA; Ramirez Gonzalez A; Chang Blanc D; Zaffran M; Patel M
Expert Rev Vaccines; 2016 Jun; 15(6):693-708. PubMed ID: 26751187
[TBL] [Abstract][Full Text] [Related]
2. Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.
Lopalco PL
Epidemiol Infect; 2017 Feb; 145(3):413-419. PubMed ID: 27866483
[TBL] [Abstract][Full Text] [Related]
3. Exploring the path to polio eradication: insights from consecutive seroprevalence surveys among Pakistani children.
Hussain I; Umer M; Khan A; Sajid M; Ahmed I; Begum K; Iqbal J; Alam MM; Safdar RM; Baig S; Voorman A; Partridge J; Soofi S
Front Public Health; 2024; 12():1384410. PubMed ID: 38601488
[TBL] [Abstract][Full Text] [Related]
4. Immunity and field efficacy of type 2-containing polio vaccines after cessation of trivalent oral polio vaccine: A population-based serological study in Pakistan.
Voorman A; Habib MA; Hussain I; Muhammad Safdar R; Ahmed JA; Weldon WC; Ahmed I; Umer M; Partridge J; Soofi SB
Vaccine X; 2020 Aug; 5():100067. PubMed ID: 32462141
[TBL] [Abstract][Full Text] [Related]
5. Analysis of population immunity to poliovirus following cessation of trivalent oral polio vaccine.
Voorman A; Lyons H; Bennette C; Kovacs S; Makam JK; F Vertefeuille J; Tallis G
Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A85-A92. PubMed ID: 35339308
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of vaccine derived poliovirus type 2 outbreak response options: A randomized controlled trial, Karachi, Pakistan.
Saleem AF; Yousafzai MT; Mach O; Khan A; Quadri F; Weldon WC; Oberste MS; Zaidi SS; Alam MM; Sutter RW; Zaidi AKM
Vaccine; 2018 Mar; 36(13):1766-1771. PubMed ID: 29477307
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa.
Cooper LV; Bandyopadhyay AS; Gumede N; Mach O; Mkanda P; Ndoutabé M; Okiror SO; Ramirez-Gonzalez A; Touray K; Wanyoike S; Grassly NC; Blake IM
Lancet Infect Dis; 2022 Feb; 22(2):284-294. PubMed ID: 34648733
[TBL] [Abstract][Full Text] [Related]
8. Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study.
Taniuchi M; Famulare M; Zaman K; Uddin MJ; Upfill-Brown AM; Ahmed T; Saha P; Haque R; Bandyopadhyay AS; Modlin JF; Platts-Mills JA; Houpt ER; Yunus M; Petri WA
Lancet Infect Dis; 2017 Oct; 17(10):1069-1079. PubMed ID: 28693854
[TBL] [Abstract][Full Text] [Related]
9. Routine Immunization Coverage and Immunization Card Retention in Pakistan: Results From a Cross-sectional National Survey.
Hussain I; Khan A; Rhoda DA; Ahmed I; Umer M; Ansari U; Shah MA; Yunus S; Brustrom J; Oelrichs R; Soofi SB; Bhutta ZA
Pediatr Infect Dis J; 2023 Mar; 42(3):260-270. PubMed ID: 36728580
[TBL] [Abstract][Full Text] [Related]
10. Poliovirus Immunity among Children Aged 6-11 and 36-48 Months in 14 Polio High-Risk Provinces of Afghanistan: A Health-Facility-Based Study.
Soofi SB; Martinez M; Farag NH; Hendley WS; Ehrhardt D; Ahmed I; Hussain I; Weldon W; Kassem AM
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298591
[TBL] [Abstract][Full Text] [Related]
11. A Survey to Assess Serological Prevalence of Poliovirus Antibodies in Areas With High-Risk for Vaccine-Derived Poliovirus Transmission in Chad.
Gamougam K; Jeyaseelan V; Jones KAV; Mainou BA; Palmer T; Diaha A; Wiesen E; Ntezayabo B; Ayangma R; Soke NG; Samba D; Okiror S; Mach O
J Pediatric Infect Dis Soc; 2022 Feb; 11(2):55-59. PubMed ID: 34791366
[TBL] [Abstract][Full Text] [Related]
12. Impact of COVID-19 on polio vaccination in Pakistan: a concise overview.
Din M; Ali H; Khan M; Waris A; Ullah S; Kashif M; Rahman S; Ali M
Rev Med Virol; 2021 Jul; 31(4):e2190. PubMed ID: 33176028
[TBL] [Abstract][Full Text] [Related]
13. Progress Toward Poliovirus Containment Implementation - Worldwide, 2019-2020.
Moffett DB; Llewellyn A; Singh H; Saxentoff E; Partridge J; Boualam L; Pallansch M; Wassilak S; Asghar H; Roesel S; Grabovac V; Rey-Benito G; Barnor J; Theo A; Swan J; Iakovenko M; Baig N; Gurung S; Pandel E; Zaffran M
MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(37):1330-1333. PubMed ID: 32941411
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 in Pakistan: Impact on global polio eradication initiative.
Haqqi A; Zahoor S; Aftab MN; Tipu I; Rehman Y; Ahmed H; Afzal MS
J Med Virol; 2021 Jan; 93(1):141-143. PubMed ID: 32603503
[No Abstract] [Full Text] [Related]
15. Progress Toward Polio Eradication - Worldwide, January 2018-March 2020.
Chard AN; Datta SD; Tallis G; Burns CC; Wassilak SGF; Vertefeuille JF; Zaffran M
MMWR Morb Mortal Wkly Rep; 2020 Jun; 69(25):784-789. PubMed ID: 32584798
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
